ArticleJournal of the American Society of Nephrology : JASN2018
Open access · bronzeAbstract read
In one paragraph
Article in Journal of the American Society of Nephrology : JASN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 2 pooled it
8.3field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
67 citing papers in PubMed, 2 syntheses or guidelines pooled it, 107 citations in OpenAlex.
- Systematic review of outcomes reported in clinical research on nephronophthisis: how do they align with SONG Kids priorities?Pediatric nephrology (Berlin, Germany) · 2026Pooled it
- Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Kidney international · 2022Guideline
- Modeling Complex Developmental Disease: The Case of Polycystic Kidney Disease.Journal of developmental biology · 2026Review
- Chronic Kidney Disease in Children with Suspected Genetic Etiology: Diagnostic Yield and Clinical Implications.Journal of personalized medicine · 2026Article
- Genetic testing in chronic kidney disease of uneXplained cause (CKDx): clinical insights and evolving diagnostic paradigms.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2026Article
- Article
- Response to the Letter to the Editor Entitled "From Variant of Unknown Significance to Likely Pathogenic: Adult-Onset - Nephronophthisis Linked to NPHP4 p.T680M".Kidney international reports · 2025Article
- Urinary renal epithelial cells can be used for NPHP1 phenotyping and a personalized therapeutic strategy.Journal of cell science · 2025Article
- Elucidating Mechanisms of Hypomorphic WDR19-Related Kidney Failure.Kidney international reports · 2025Article
- iPSC-based drug discovery identified the Hippo signaling pathway as a therapeutic target in the fibrosis of NPHP1-deficient nephronophthisis.Stem cell research & therapy · 2025Article
- Nephrogenomics, precision medicine and the role of genetic testing in adult kidney disease management.Nature reviews. Nephrology · 2025Review
- Ameliorative Effect of an Anti-MicroRNA-21 Oligonucleotide on Animal and Human Models of Cystic Kidney Disease.Kidney360 · 2025Article
- Gene Editing: An Effective Tool for the Future Treatment of Kidney Disease.Journal of inflammation research · 2025Review
- Expanding the phenotypic spectrum of CC2D2A-related ciliopathies: a rare homozygous nonsense variant in a patient with suspected nephronophthisis.European journal of human genetics : EJHG · 2024Article
- The Role of Genetic Testing in Adult CKD.Journal of the American Society of Nephrology : JASN · 2024Article
- Genetic landscape and clinical outcomes of autosomal recessive polycystic kidney disease in Kuwait.Heliyon · 2024Article
- The role of genomic disorders in chronic kidney failure of undetermined aetiology ≤50 years.Clinical kidney journal · 2024Article
- Objectivizing issues in the diagnosis of complex rare diseases: lessons learned from testing existing diagnosis support systems on ciliopathies.BMC medical informatics and decision making · 2024Article
- Article
- Genetic Diagnosis of Adult Hemodialysis Patients With Unknown Etiology.Kidney international reports · 2024Article
7 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
25 authors at 9 institutions in 6 countries.
Rozemarijn SnoekDepartments of Genetics and.
Jessica van SettenCardiology and.
Brendan J KeatingDepartment of Surgery, Penn Transplant Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Ajay K IsraniDepartment of Medicine, Hennepin County Medical Center.
Pamala A JacobsonCollege of Pharmacy, and.
William S OettingCollege of Pharmacy, and.
Arthur J MatasDepartment of Surgery, University of Minnesota, Minneapolis, Minnesota.
Roslyn B MannonDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Zhongyang ZhangDepartment of Genetics and Genomic Sciences.ORCID 0000-0002-2521-3884
Weijia ZhangDivision of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Ke HaoDepartment of Genetics and Genomic Sciences.
Barbara MurphyDivision of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Roman Reindl-SchwaighoferDivision of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Andreas HeinzlDivision of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-8447-1795
Rainer OberbauerDivision of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Ondrej ViklickyDepartment of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Peter J ConlonDepartment of Molecular and Cellular Therapeutics, Royal College of Surgeons, Dublin, Ireland.ORCID 0000-0001-6772-9531
Caragh P StapletonDepartment of Molecular and Cellular Therapeutics, Royal College of Surgeons, Dublin, Ireland.
Stephan J L BakkerDepartments of Nephrology.
Harold SniederEpidemiology, and.
Edith D J PetersDepartments of Genetics and.
Bert van der ZwaagDepartments of Genetics and.
Nine V A M KnoersDepartments of Genetics and.
Martin H de BorstDepartments of Nephrology.ORCID 0000-0002-4127-8733
Albertien M van EerdeDepartments of Genetics and a.vaneerde@umcutrecht.nl.
Utrecht University · NLChildren's Hospital of Philadelphia · USMedical University of Vienna · ATPediatrics and Genetics · USUniversity of Minnesota · USHennepin County Medical Center · USInstitute of Clinical and Experimental Medicine · CZUniversity Medical Center Groningen · NLUniversity of Alabama at Birmingham · US
Funding
Pharmacogenomics of Immune Suppressants in Kidney TransplantationU19AI070119 · NIAID · UNIVERSITY OF MINNESOTA · PI MATAS, ARTHUR J · 2006 to 2016
$17.1MLong-term Deterioration of Kidney Allograft FunctionU01AI058013 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MATAS, ARTHUR J · 2005 to 2010
$10.2MNIAID NIH HHS U01 AI058013NIAID NIH HHS U19 AI070119
Abstract
PubMed holds no abstract for this paper.
Indexed as
Adaptor Proteins, Signal TransducingAdolescentAdultAge FactorsCytoskeletal ProteinsFemaleGene DeletionGene DosageHomozygoteHumansIncidenceKidney Diseases, CysticKidney Failure, ChronicMaleMembrane ProteinsMiddle AgedAdaptor Proteins, Signal TransducingCytoskeletal ProteinsMembrane ProteinsNPHP1 protein, humancystic kidneyend-stage renal diseasegenetic renal diseasehuman geneticstransplantation
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.